155 related articles for article (PubMed ID: 12900843)
1. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
Colville D; Guymer R; Sinclair RA; Savige J
Am J Kidney Dis; 2003 Aug; 42(2):E2-5. PubMed ID: 12900843
[TBL] [Abstract][Full Text] [Related]
2. [Ocular impairment during type II membranoproliferative glomerulonephritis].
Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
[TBL] [Abstract][Full Text] [Related]
3. Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
Savige J; Amos L; Ierino F; Mack HG; Symons RC; Hughes P; Nicholls K; Colville D
Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis.
D'souza Y; Short CD; McLeod D; Bonshek RE
Br J Ophthalmol; 2008 Jul; 92(7):950-3. PubMed ID: 18577648
[TBL] [Abstract][Full Text] [Related]
5. [Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green].
Parrat E; Arndt CF; Labalette P; Boulanger E; Hache JC; Constantinides G; Dequiedt P
J Fr Ophtalmol; 1997; 20(6):430-8. PubMed ID: 9296039
[TBL] [Abstract][Full Text] [Related]
6. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.
Levy Y; George J; Yona E; Shoenfeld Y
Immunol Res; 1998 Aug; 18(1):55-60. PubMed ID: 9724849
[TBL] [Abstract][Full Text] [Related]
7. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II].
Framme C; Herboth T; Roider J; Laqua H
Klin Monbl Augenheilkd; 1998 Oct; 213(4):252-3. PubMed ID: 9848073
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
[TBL] [Abstract][Full Text] [Related]
9. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
[TBL] [Abstract][Full Text] [Related]
10. Retinal function abnormalities in membranoproliferative glomerulonephritis type II.
Kim RY; Faktorovich EG; Kuo CY; Olson JL
Am J Ophthalmol; 1997 May; 123(5):619-28. PubMed ID: 9152067
[TBL] [Abstract][Full Text] [Related]
11. A long history of dense deposit disease.
Cunningham A; Kotagiri A
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):228. PubMed ID: 30255792
[TBL] [Abstract][Full Text] [Related]
12. Retinal manifestations in patients with complement-mediated membranoproliferative glomerulonephritis.
de-Pablo-Gómez-de-Liaño L; Cañas Zamarra I; Fernández-Vigo JI; Fernández Vidal M; Navarro-Perea C; Cavero Escribano T
Arch Soc Esp Oftalmol (Engl Ed); 2019 Feb; 94(2):95-99. PubMed ID: 30078750
[TBL] [Abstract][Full Text] [Related]
13. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.
Leys A; Michielsen B; Leys M; Vanrenterghem Y; Missotten L; Van Damme B
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):499-504. PubMed ID: 2265764
[TBL] [Abstract][Full Text] [Related]
14. Retinal findings in glomerulonephritis.
Mack HG; Colville DJ; Harraka P; Savige JA; Invernizzi A; Fraser-Bell S
Clin Exp Optom; 2022 Jul; 105(5):474-486. PubMed ID: 34877922
[TBL] [Abstract][Full Text] [Related]
15. C3 nephritic factor and mesangiocapillary glomerulonephritis.
Williams DG
Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
[TBL] [Abstract][Full Text] [Related]
16. Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis.
Tanner A; Chan HW; Stears A; Moosajee M
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155011
[TBL] [Abstract][Full Text] [Related]
17. Mesangiocapillary glomerulonephritis.
D'Amico G; Ferrario F
J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S159-66. PubMed ID: 1534701
[TBL] [Abstract][Full Text] [Related]
18. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.
Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):406-10. PubMed ID: 1937071
[TBL] [Abstract][Full Text] [Related]
19. Ocular complications after kidney transplantation: a case report and review of literature.
Abazi Z; Magarasevic L; Sukalo S; Kosanovic-Jakovic N; Risovic D
Int Urol Nephrol; 2014 Mar; 46(3):665-8. PubMed ID: 24402231
[TBL] [Abstract][Full Text] [Related]
20. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
